FDA recalls certain Baxter-manufactured IV solutions

After fielding customer complaints about leaks and particulate matter, Baxter International is voluntarily recalling four lots of hospital intravenous solutions, according to a Food and Drug Administration release.

Advertisement

Baxter sent notification letters to customers and is offering credit for returned products. Leaking containers can result in contamination of the solution and ultimately sepsis, among other adverse events. IV solutions containing particulates put patients at risk of stroke, organ damage or heart attack from blocked blood vessels, according to the release.

The recall includes lot numbers with the following product codes: 2B0043, 2B7721 and 2B3421. More information here.

More articles on quality:

8 California hospitals fined for medical errors
Baystate hospital warns nearly 300 patients of infection risk from dirty scope
CMS issues final report on overall hospital star ratings methodology

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The 2 KPIs that drive readmissions — and how hospitals act on them in real time

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenter: Nik Rao, Dexur

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.